Show simple item record

AuthorVesovic, Zoricadc.contributor.author
Date of accession2016-03-14T13:40:09Zdc.date.accessioned
Available in OPARU since2016-03-14T13:40:09Zdc.date.available
Year of creation2005dc.date.created
AbstractFamilial history is one of the strongest risks factor for prostate cancer. One of the prostate cancer candidate genes is the CYP17 gene. A thymidine (T) to cytosine (C) transition (designated A2 variant) in the promoter region of the CYP17 gene has been used in several studies in order to determine a possible association with the prostate cancer risk. A recent meta-analysis found no effect of the CYP17 polymorphism for the sporadic prostate cancer. The question still remained unresolved for familial cases. In order to evaluate the role of the CYP17 A2 allele in familial aggregation of prostate cancer we performed an association study. In our study we realized a slight difference of CYP17 genotypes between sporadic cases and controls, but this unequal distribution was not significant. Our results showed no evidence that the CYP17 genotype might predispose for a familial aggregation of prostate cancer. Our results do not suggest a role of CYP17 as a high-risk susceptibility gene for familial prostate cancer nor as a modifier for the disease risk. Rare germline mutations of the macrophage scavenger receptor 1 (MSR1) gene were reported to be associated with prostate cancer risk in families with hereditary prostate cancer (HPC) and in probands with non-HPC. For the purpose of our study 6 length polymorphisms that span approximately 70kb of the MSR1 gene were used. One of the markers (IVS6 marker) was not in the HWE, so it was excluded from the further analysis. The results gained from analysing the five length polymorphisms did not lead to overall significant results concerning the allele and haplotype frequency distribution between the cases and controls. Some allelic transmission imbalance was seen in the INDEL1 marker when families were analysed with family-based association approach. Taken together our results do not support MSR1 as a high-risk gene for prostate cancer.dc.description.abstract
Languageendc.language.iso
PublisherUniversität Ulmdc.publisher
LicenseStandard (Fassung vom 03.05.2003)dc.rights
Link to license texthttps://oparu.uni-ulm.de/xmlui/license_v1dc.rights.uri
KeywordCYP17dc.subject
KeywordMSR1dc.subject
Dewey Decimal GroupDDC 610 / Medicine & healthdc.subject.ddc
MeSHProstatic neoplasms. Geneticsdc.subject.mesh
TitleMolecular genetic of prostate cancer: association of the candidate genes CYP17 and MSR1dc.title
Resource typeDissertationdc.type
DOIhttp://dx.doi.org/10.18725/OPARU-575dc.identifier.doi
URNhttp://nbn-resolving.de/urn:nbn:de:bsz:289-vts-54114dc.identifier.urn
GNDProstatakrebsdc.subject.gnd
FacultyMedizinische Fakultätuulm.affiliationGeneral
Date of activation2005-11-30T15:01:45Zuulm.freischaltungVTS
Peer reviewneinuulm.peerReview
Shelfmark print versionZ: J-H 10.915 ; W: W-H 8.862uulm.shelfmark
DCMI TypeTextuulm.typeDCMI
VTS-ID5411uulm.vtsID
CategoryPublikationenuulm.category
University Bibliographyjauulm.unibibliographie


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record